Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system

Immunity
M PrinzUlrich Kalinke

Abstract

The action of type I interferons in the central nervous system (CNS) during autoimmunity is largely unknown. Here, we demonstrate elevated interferon beta concentrations in the CNS, but not blood, of mice with experimental autoimmune encephalomyelitis (EAE), a model for CNS autoimmunity. Furthermore, mice devoid of the broadly expressed type I IFN receptor (IFNAR) developed exacerbated clinical disease accompanied by a markedly higher inflammation, demyelination, and lethality without shifting the T helper 17 (Th17) or Th1 cell immune response. Whereas adoptive transfer of encephalitogenic T cells led to enhanced disease in Ifnar1(-/-) mice, newly created conditional mice with B or T lymphocyte-specific IFNAR ablation showed normal EAE. The engagement of IFNAR on neuroectodermal CNS cells had no protective effect. In contrast, absence of IFNAR on myeloid cells led to severe disease with an enhanced effector phase and increased lethality, indicating a distinct protective function of type I IFNs during autoimmune inflammation of the CNS.

References

Jul 1, 1990·Statistics in Medicine·Y Hochberg, Y Benjamini
Mar 15, 1997·Nucleic Acids Research·R C RickertK Rajewsky
Nov 24, 1999·Neurology·M E KozovskaJ Z Zhang
Nov 20, 2001·Nature Immunology·C Asselin-PaturelG Trinchieri
Sep 24, 2002·Nature Immunology·Simon FillatreauStephen M Anderton
Oct 16, 2002·Glia·Uwe-Karsten Hanisch
Feb 26, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sarah L PoguePina M Cardarelli
Jan 28, 2006·The Journal of Clinical Investigation·Marco PrinzBurkhard Becher
Mar 3, 2006·The New England Journal of Medicine·Elliot M FrohmanCedric S Raine
May 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sophie DelhayeThomas Michiels
Jun 7, 2006·Journal of Neuroimmunology·Sandra HeineMartin Stangel
Nov 14, 2006·Bioinformatics·S Falcon, R Gentleman
Mar 23, 2007·Annals of the New York Academy of Sciences·Stephen D MillerSamantha L Bailey

❮ Previous
Next ❯

Citations

Nov 2, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Carol A Colton
Jan 11, 2012·Clinical Reviews in Allergy & Immunology·Robert C AxtellLawrence Steinman
Apr 4, 2013·Cytokine & Growth Factor Reviews·Markus J Hofer, Iain L Campbell
Jun 3, 2009·Immunology and Cell Biology·Paula KeatingAnne C La Flamme
Mar 14, 2012·Immunology and Cell Biology·Nicole A de Weerd, Thao Nguyen
Oct 6, 2009·Nature Genetics·Ann-Marie BröskeFrank Rosenbauer
Jun 7, 2008·Nature Medicine·Thomas Prod'homme, Scott S Zamvil
Dec 20, 2008·Nature Reviews. Immunology·Harvey Cantor, Mari L Shinohara
Jan 10, 2012·Nature Reviews. Immunology·José M González-NavajasEyal Raz
Dec 24, 2013·Nature Reviews. Immunology·Lionel B Ivashkiv, Laura T Donlin
Nov 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Joana A ZulaAnette H H van Boxel-Dezaire
Feb 4, 2010·The Journal of Experimental Medicine·Manira RayamajhiLaurel L Lenz
Sep 21, 2011·The Journal of Experimental Medicine·Mark S DiamondRobert D Schreiber
Sep 15, 2010·The Journal of Experimental Medicine·Giorgio Trinchieri
Jan 23, 2013·The Journal of Experimental Medicine·Francesca PreteFederica Benvenuti
Sep 30, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jian Hong, George J Hutton
Jun 18, 2009·Brain : a Journal of Neurology·Alexander MildnerMarco Prinz
Jun 22, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D HesseF Sellebjerg
Nov 5, 2008·The Journal of Clinical Investigation·Lawrence Steinman
Dec 27, 2011·Journal of Neuroinflammation·Mohammad SalemTrevor Owens
Apr 16, 2010·Arthritis Research & Therapy·George D Kalliolias, Lionel B Ivashkiv
Feb 9, 2010·PLoS Pathogens·Saskia L SmitsBart L Haagmans
Apr 20, 2014·PLoS Pathogens·Amelia K PintoMichael S Diamond
Mar 21, 2012·Critical Reviews in Immunology·Shankar Subramanian Iyer, Gehong Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.